Basilar artery occlusions (BAOs) are a subset of posterior circulation strokes. Particular issues relevant to BAOs include variable and stuttering symptoms at onset resulting in delays in diagnosis, high morbidity and mortality, and uncertain best management. Despite better imaging techniques, diagnosis, and therefore treatment, is often delayed. We will present the most common signs and symptoms of posterior circulation strokes. Data on optimal treatment strategies are gathered from multiple case series, registries, and one randomized trial, which was stopped early. Possible etiologies of BAOs, acute, and subacute treatment strategies and special topics in neuroimaging of the posterior fossa are discussed. This review may be helpful to neurohospitalists who are managing patients with acute stroke as well as emergency room physicians and neurologists.
Introduction
Basilar artery occlusion (BAO) is a potentially fatal diagnosis, yet it is one of the most challenging conditions for clinicians to diagnose and manage. Posterior circulation strokes account for about 15% to 20% of all ischemic strokes. The BAO is a subset of this category, representing 1% to 4% of all ischemic strokes. Unlike hemispheric ischemia, where there is usually sudden onset of focal symptoms, BAO syndromes may mimic other nonstroke conditions, resulting in a delay in neurological evaluation. 1 A more sophisticated neurological examination may help to decipher a posterior circulation syndrome from other clinical diagnoses. Clinical features localizing to the brainstem or cerebellum such as truncal ataxia, nystagmus, extraocular movement abnormalities, and hearing loss, may help to differentiate ischemia in the posterior circulation from other clinical diagnoses. Yet even when the appropriate diagnosis is made, the best management is not well defined. Within 2 weeks of each other, our stroke team saw and treated 2 BAOs with similar presentations but with markedly different outcomes ( Figure 1 ). These cases demonstrate several points: (1) Diagnosing a BAO syndrome can be difficult for family, first responders, and physicians. (2) The best treatment for patients with acute BAO is uncertain but there are several reasonable options based upon current data.
We discuss presentation, causes, and current opinions for treatment of BAO with the neurohospitalist's perspective in mind. Many of these topics have been addressed in a recent review in Lancet Neurology by Mattle et al. 12 
Posterior Circulation Anatomy
The posterior cerebral circulation is the blood supply to the posterior portion of the brain including the brainstem, thalami, cerebellum, and occipital lobes. Bilateral vertebral arteries originate from the subclavian arteries and join at the pontomedullary junction to form a singular basilar artery (BA). The BA can be divided into three segments: a proximal, middle, and distal segment. The distal tip of the BA divides into bilateral posterior cerebral arteries (PCAs), which supply the occipital lobes, the inferior temporal lobes, and the medial parietal lobes via major arterial branches and the thalamus and upper midbrain via perforating arteries that arise from the PCAs. Other important branches of the BA include the superior cerebellar arteries (SCAs), the anterior inferior cerebellar arteries, and pontine perforating arteries. The posterior inferior cerebellar arteries usually originate from the vertebral arteries. The location of arterial occlusion relates closely with symptoms. Figure 1 . Clinical presentation and angiographic comparison of 2 cases of basilar artery occlusion seen at the University Hospital within 1 week of each other meant to illustrate similarities and differences of etiology, symptoms at onset, and outcomes. The arrow points out a persistent high-grade mid-basilar stenosis after recanalization in case 2.
Basilar Occlusion Syndromes
The BAO syndrome presents as a subset of the larger category of posterior circulation strokes. Compared to anterior circulation stroke syndromes, posterior circulation ischemia may have a longer prodrome and an evolution that is important to recognize. The latency between first prodromal symptoms and stroke onset can be from days to months before stroke onset and may increase in frequency as the stroke approaches. 13, 14 Most common prodromal symptoms are vertigo and nausea, followed by headache and neck pain. 15, 16 ''Herald hemiparesis'' refers to the transient, lateralized motor weakness that may precede the stroke. Dizziness and vertigo, common early symptoms of BAO, are nonspecific, accounting for about 4 million emergency department visits annually in the United States. Distinguishing between central and peripheral vertigo is clinically important as delayed recognition of vascular vertigo leads to missed opportunities for thrombolysis and/or thrombectomy and may increase risk of death and disability.
Head impulse, nystagmus type, and test of skew (HINTS) is a sensitive clinical decision tool, more often used by specialists, which can be used to help distinguish between central and peripheral vertigo. It has been shown to outperform magnetic resonance imaging (MRI) in diagnosing stroke within the first 2 days of acute dizziness symptoms. 2 Use of a stroke risk-stratification tool such as the ABCD2 score, which assigns points (0-7) based on 5 clinical factors: age 60 years or older ¼ 1; blood pressure 140/90 ¼ 1; clinical features (unilateral weakness ¼ 2, speech disturbance without weakness ¼ 1, and any other symptom ¼ 0); duration of symptoms (<10 minutes ¼ 0, 10-59 minutes ¼ 1, and 60 minutes ¼ 2); and diabetes ¼ 1, may also help to stratify higher risk patients. 1.0% of dizzy patients with an ABCD2 score of 3 or less ultimately received a diagnosis of stroke compared with 6.8% of patients with a score of 4 or 5 and 27% with a score of 6 or 7. 3 Time to follow-up and neuroimaging were variable between patients.
The neurological examination should be used to look for additional localizing signs and symptoms. A patient with dizziness plus one other neurological symptom is much more likely to have a vascular etiology of their symptoms than a patient with isolated vertigo. Fewer than 1% of patients with vertebrobasilar ischemia (VBI) in the New England Medical Center Posterior Circulation Registry had only 1 presenting symptom or sign. 4 Oculomotor palsies, oropharyngeal dysfunction, truncal and appendicular ataxia, and limb weakness are the most common signs. 16 Other findings in VBI include abnormal eye movements, 5 asymmetric pupils, dysmetria, respiratory disturbance, and altered level of consciousness. Vertical or alternating horizontal nystagmus in primary gaze is of central etiology until proven otherwise. Descending unilateral or bilateral long upper motor tracts and crossing cerebellar fibers located in the paramedian pons are frequently affected with accompanying combinations of weakness and ataxia.
The severity of presentation can vary from isolated cranial nerve palsies to tetraplegia, locked-in state, or coma. Acute BAO may mimic other neurological syndromes such as benign paroxysmal positional vertigo, delirium, or coma. Other misleading presentations of acute BAO include either unilateral or bilateral shaking, twitching, jerking, or posturing which can potentially be mistaken for epileptic events. 17 Symptoms may be bilateral or ''crossed'' (ie, left face weakness with right arm and leg weakness), which can present a diagnostic challenge if suspicion for posterior circulation stroke is not high.
One of the most devastating locations for a BAO is a midbasilar occlusion with bilateral pontine ischemia. These patients may appear to be comatose but can be fully conscious and paralyzed with only limited vertical eye movements. This ''locked-in syndrome'' has a high mortality rate of approximately 75% in the acute phase. 18 Another BAO syndrome involves occlusion at the distal top of the BA where the SCAs and PCAs represent the final terminal branches. This ''top of the basilar'' syndrome may cause ischemia of the midbrain, thalami, inferior temporal lobes, and occipital lobes. Occlusion of paramedian perforator branches, which originate from the distal BA, results in midbrain and thalamic ischemia. Examination findings may include vertical gaze and convergence disorders, slowed smooth pursuit movements, skew deviation, 19 see-saw, and convergence-retraction nystagmus. Pupillary light reflex is often affected such that pupils react to light slowly and incompletely or not at all. If SCAs are involved, then dizziness, vomiting, dysarthria, ipsilateral or bilateral dysmetria, and gait ataxia may be observed with ischemia of the superior cerebellum. An embolus to one PCA can result in contralateral vision loss, whereby infarction of both PCA territories can cause cortical blindness, disorientation, and inability to form new memories.
Infarction of the middle midbrain can result in nuclear third nerve palsy or fascicular third nerve palsy, which can be associated with crossed hemiplegia, ipsilateral, or contralateral hemiataxia. An infarct in the lower midbrain can cause internuclear ophthalmoplegia (INO), fourth nerve palsy, and bilateral ataxia. Long anteromedial perforators arise from the mid-basilar portion of the artery. Occlusion of the mid-BA that supply the pons and lower midbrain can also result in prominent eye findings including primary-position, downbeating nystagmus, ipsilateral gaze paralysis (ipsilateral or complete), and INO (both unilateral and bilateral).
Infarcts in the paramedian pons cause pure unilateral motor strokes with or without incoordination (ataxic hemiparesis). Ocular bobbing can be seen in pontine strokes. Less common are lateral pontine syndromes like Gasperinin syndrome, which comprises abducens palsy plus complete anterior inferior cerebellar artery syndrome.
Mechanisms for BAOs
The most common causes of posterior circulation ischemia are similar to causes of anterior circulation strokes and include embolism, large-artery atherosclerosis, penetrating smallartery disease, and arterial dissection. Intrinsic atherosclerotic BA stenosis is the most common cause and occurs most often in the sixth and seventh decade of life. The BAO secondary to embolism from the heart or vertebral arteries is another significant cause. Patients with embolic etiology are younger than those with atherosclerotic disease. 14 Dissection of a vertebral artery can either expand directly into the wall of the BA resulting in low-flow or no-flow state, or cause formation of a thrombus that can embolize distally. Traumatic vertebral artery dissection is one of the most common causes of acute BAO in young patients and should be suspected in patients presenting with cervical pain with or without headache and neurological deterioration. 20 Rarer causes which are more specific to the posterior circulation include cervical spine or skull base fracture, cervical instability, 21, 22 arteritis, meningitis, aneurysms, hereditary arteriopathies, and neurosyphilis. 23 Behcet vasculitis more commonly involves the posterior circulation. 24 A large number of posterior circulation strokes remain cryptogenic.
Special Topics in Imaging of BAO and Posterior Fossa
Although a noncontrast head computed tomography (CT) is sensitive to detect an intracranial hemorrhage, it is not particularly sensitive for diagnosis of acute ischemic stroke, especially in the posterior fossa. A hyperdense BA sign, presumed to represent acute thrombus or clot, can be seen on a noncontrast head CT in 50% to 70% of patients with BA thrombosis ( Figure 2B ). 26 Overall, the sensitivity, specificity, and reliability of this finding are low and in most cases should not be used to direct patient care. 27 However, in patients where there is a high pretest probability of posterior circulation stroke, the presence of a hyperdense BA is a specific predictor of BAO. 28 When a hypodensity is seen in the posterior circulation territory on the CT scan, the posterior circulation Acute Stroke Prognosis Early CT score (pc-ASPECTS), developed and validated by Volker Puetz, can be used to quantify early ischemia. This scoring system allots the posterior circulation 10 points in total with points subtracted for ischemic changes. One point is subtracted for changes in the left or right thalamus, cerebellum, or PCA territory and 2 points are subtracted for any hypodensity in the midbrain or pons, 9 as shown in Figure 2A . The same scoring system used on source images from a CT angiogram has a higher sensitivity for predicting final infarct size and those who will have poor functional outcome, despite recanalization of the BA. 9, 29 An MRI of the brain is more sensitive than a noncontrast head CT for detection of acute stroke. The diffusionweighted imaging (DWI) sequence paired with an apparent diffusion coefficient map are the most sensitive sequences for acute stroke. However, it is estimated that 6% to 10% of all strokes are initially DWI negative [30] [31] [32] with more false-negative MRIs occurring in cases of posterior circulation stroke. 50% of patients with a stroke who present with isolated vertigo will have a falsely negative MRI up to 48 hours after onset. 25 A recent article by Simonsen et al found DWI negative strokes were twice as likely in the posterior circulation (34% vs 15%), but the sensitivity of DWI seems variable within the literature. 31, 32 The sensitivity of MRI increases with time from symptom onset to imaging. Therefore, a posterior circulation stroke should not be ruled out with an early negative MRI, especially with persistent neurological deficits. The Pc-ASPECT score of 8 or more on MRI (or CT angiogram) is an independent predictor of favorable outcomes, 33 whereas cerebral blood volume pc-ASPECTS <8 may indicate patients with high case fatality. 34 With regard to vascular imaging, computed tomography angiography (CTA) and MRA have greater sensitivity than transcranial Doppler and Doppler studies of the vertebral arteries in the neck, which can only grossly comment on the presence and direction of flow in the vertebral arteries. The gold standard for vascular imaging is cerebral angiogram and should be considered when initial, noninvasive imaging is nondiagnostic or conflicting.
Acute Treatment of BAO
There is no consensus for the best acute management of BAOs. If suspected, the first critical step is to verify that the patient can protect his or her airway, as acute BAO symptoms can progress to decreased alertness, decreased respiratory drive, and coma. The treating clinician should consider augmenting blood pressure to increase cerebral perfusion by lying the head of bed flat. A noncontrast head CT and CT angiography should be the next step in diagnostic testing. If the head CT shows no hemorrhage and symptom onset is within 4.5 hours, IV tissue-type plasminogen activator (t-PA) is standard of care. The high morbidity and mortality in patients with BAO who do not recanalize 7 may lead to consideration of endovascular treatment to revascularize the BA by intraarterial thrombolysis or thrombectomy. However, no large, definitive, randomized, clinical trials have compared thrombectomy using clot retrieval devices following best medical therapy (IV t-PA within 4.5 hours or best medical therapy after 4.5 hours) as compared to best medical therapy alone.
Case series and retrospective studies provide some insight into the natural history of BAOs and the importance of recanalization. Prior to 2006, data were solely from case series or minimal data from acute stroke trials. In Interventional Management of Stroke III, a randomized, controlled study comparing IV t-PA to IV t-PA þ endovascular treatment, there were only 5 patients enrolled with occlusions within the posterior circulation. 35 There was no outcome difference between the 2 groups in this small subset of patients. The Australian Urokinase Stroke Trial (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) was the 1 randomized, controlled trial directly comparing best medical therapy to intra-arterial urokinase but was stopped early due to slow recruitment and the withdrawal of urokinase from clinical use. 36 Prior to study withdrawal, 16 patients were randomized into 2 arms. In all, 8 patients received heparin and warfarin and 8 received urokinase, heparin, and warfarin. Of the 8 patients, 7 were dead or disabled in the anticoagulation arm and 4 of the 8 patients in the urokinase arm were dead or disabled at 6 months (P ¼ .28). Median time to treatment was approximately 12 hours in either group, and time did not seem to affect outcome.
New technology for intra-arterial treatment (IAT) of stroke (ie, stent retrievers) is available and currently being used for clot removal in the posterior circulation. A meta-analysis of uncontrolled studies comparing IAT to IV t-PA (N ¼ 420; 76 IV t-PA, 344 endovascular) showed no difference in death or dependency between groups. 37 In all, 77.6% of IV t-PAtreated patients and 75.6% of IAT patients who presented with BAO had poor outcomes, despite higher recanalization rates in the IAT group (65% vs 53%). Rates of hemorrhagic infarction were not significantly different between groups. Recanalization was a factor associated with good outcome (38% in patients with some recanalization vs 2% in those without any recanalization). 37 In addition, a recently published multicenter registry, ENDOSTROKE, enrolled 148 patients with angiographic proven BAOs between January 2011 and June 2013. In all, 84% of patients were treated with a stent retriever either as the only device or in combination with others. In all, 34% of patients had good clinical outcomes (independence) while mortality was 35%. In this cohort of patients, lower National Institutes of Health Stroke Scale (NIHSS) score, use of MRI, and better collateralization status independently predicted good clinical outcome. Recanalization was achieved in 79% but was not found to be a predictor of good outcome. 38 The Basilar Artery International Cooperation Study (BASICS) was a nonrandomized prospective registry that assessed clinical outcomes of patients with confirmed BAO between November 2002 and October 2007. 7 In this registry, most patients received endovascular therapy (+IV t-PA). The authors found no overall differences between IV t-PA alone and endovascular therapy (+IV t-PA), although IV t-PA alone was associated with better clinical outcomes as compared to endovascular therapy in patients with mild to moderate symptoms. Patients with moderate and severe symptoms did better if they received endovascular therapy or IV t-PA compared to antiplatelets or anticoagulation only. Due to nonrandomization, the treatment strategy in these patients is influenced by time, patient age, comorbid status, and stroke severity. The BASICS Trial is an ongoing randomized, controlled, multicenter, open label, and phase III interventional trial with blinded outcome assessment of efficacy and safety of additional IAT after IVT in patients with BAO. 39 The trial has been limited by slow enrollment.
Despite any direct evidence that endovascular treatment of BAO is beneficial, proponents of the endovascular therapy argue that the natural history of the disease has a poor prognosis, and reperfusion is a predictor of good outcome. Most interventionalists will perform endovascular therapy up to 6 hours from symptom onset, dependent on the severity of the patient's symptoms. Because BAO symptoms often progress to devastating neurological outcomes, some interventionalists may consider revascularization up to 24 hours after symptom onset. Successful recanalization has been performed in patients with symptoms present for up to 50 hours. 40 Strbian and colleagues conclude that recanalization of BAO up to 48 hours was seldom futile and produced good outcomes in 50% of patients independent of time to treatment. 8 However, the question remains, how much does recanalization improve outcomes and at what point are attempts to recanalize futile? Ultimately a randomized trial is warranted to determine the appropriate treatment at various time windows after stroke onset.
In-Hospital Management of BAO
After initial stabilization of the patient with a BAO, neurologists or neurohospitalists should direct a work up to determine the stroke etiology. One should obtain an MRI brain to evaluate lesion burden and edema and an MRA (or CTA) head and neck to evaluate for atherosclerotic disease, dissection, luminal narrowing, or occlusion. An echocardiogram with a bubble study should be obtained to evaluate for potential cardiac sources of emboli such as a valvular vegetation, intracardiac mass, ventricular thrombus, or patent foramen ovale. Patients should be placed on continuous cardiac monitoring to evaluate for atrial fibrillation, a finding that would change secondary stroke prevention management. Laboratory testing including CBC, fasting lipids, coagulation panel, and glycated hemoglobin A1c should be obtained. More extensive work up should be obtained on a case-by-case basis, especially in young patients without typical risk factors.
Close attention should be made to relation of symptoms to blood pressure. Patients with BAOs may be particularly sensitive to changes in blood pressure. In the first 24 to 48 hours, the blood pressure should be allowed to autoregulate. One should consider using fluids or pressors if symptoms are blood pressure dependent. Patients should be carefully monitored for cerebellar edema causing compression of the fourth ventricle and/or herniation, which generally peaks 3 to 5 days after infarction. Secondary prevention should be guided by stroke etiology. Although antithrombotics are indicated, the American Heart Association guidelines state that there is no clear indication for anticoagulation in acute stroke, with limited exceptions (ie, cardiac thrombus), which are to be considered on a case-by-case basis. 41 Outside of these guidelines, heparin drip can be considered if the patient is outside the window for acute treatment and infarct burden is minimal. The heparin drip in these difficult cases may prevent clot propagation. The size of the infarct will determine the time frame in which it is safe to initiate anticoagulation in patients in whom atrial fibrillation is detected. Although safe with small infarcts, moderate and large infarcts are subject to hemorrhagic transformation in the first 1 to 2 weeks. In general, statins should be initiated when patient can safely swallow.
Outcomes
When acute BAO was first described by Kubik and Adams by postmortem analysis, it was assumed to have a 100% mortality rate. 42 More recent reports of BAO outcomes have varied greatly due to increased detection with modern imaging techniques and better recognition of posterior stroke symptoms. In the New England registry of posterior circulation strokes, a prospective, single institution registry, only 29% of patients died or were left with a major deficit. Outcomes were dependent on the etiology of the occlusion. Those patients with embolic etiology had a 2.4-fold higher risk of poor outcome compared with patients with diffuse or localized atherosclerosis. 14 Overall, the mortality rate in their study was lower compared to previously reported findings of mortality rates of 45% to 86%. 37, 43, 44 There are some data to help guide clinicians as to which patients with BAO will have better outcomes. In a prospective study of 184 consecutive patients with angiographyproven BAO, predictors of poor outcomes included greater age, higher NIHSS score, lack of recanalization, history of atrial fibrillation, and symptomatic intracranial hemorrhage. 8 A pc-ASPECTS >8 is independently associated with better outcomes. 8, 9 Successful recanalization appears to be the single most important predictor of a good outcome. 10 The thrombolysis in cerebral infarction (TICI) score is a widely used method to describe angiographic findings after endovascular treatment of acute ischemic stroke. Although definitions vary within the literature, TICI 2b (>50% reperfusion of vascular territory according to the original TICI 45 and >67% of the vascular territory in the modified TICI 46 ) and TICI 3 (100% reperfusion) are generally regarded to represent a successful angiographic outcome. Lindsberg and Mattle found that only 2% of patients who did not recanalize the BA had good outcomes versus 38% who did. 37 In the Helsinski Stroke Thrombolysis Registry, 14% of patients who did not recanalize had good outcomes compared to 86% who did recanalize. 47 In a small case series of 6 consecutive BAO's treated at a single institution, 5 of the 6 patients treated with endovascular treatment had a TICI score of 3 and the other had TICI 2b resultant recanalization, and all but 1 patient was independent with activities of daily living at 90 days. 48 In lieu of randomized controlled trials, a recent meta-analysis by Kumar et al showed that recanalization was associated with a 1.5-fold reduction in dependency and 2.0-fold reduction in mortality. 10 Despite apparent improvements in outcomes over time, the best therapy to achieve recanalization is unknown.
Predictors of recanalization include clot location and clot length. Top of the basilar clot location 47 and shorter thrombus length 49 have increased probability of recanalization. Strbian reported that thrombi shorter than 100 mm had a 70% to 80% probability of recanalization. The probability of recanalization decreased in a clot length-dependent fashion, such that thrombi >30 mm long had only a 20% to 30% chance of opening with IV t-PA. In this study, patients with complete or partial recanalization had significantly less morbidity at 3 months and less mortality at 3 months and 1 year. 49 In addition to recanalization, other clinical and radiological variables associated with survival of BAO after systemic thrombolysis include younger age, atherothrombotic etiology, short occlusion length, and good collaterals. 50 As the technology of thrombectomy devices has improved, recanalization rates and time to recanalization have also improved. 51 Clinical outcomes data with these new devices for BA occlusion are ongoing.
Summary
The morbidity and mortality of BAO remain high, despite advances in stroke prevention and treatment in ischemic stroke (please also refer to Table 1 ). There should be a high index of suspicion for a BAO in a patient with dizziness plus any other neurological deficit, particularly fluctuating level of consciousness, diplopia (or abnormal eye movements on examination), or unsteady gait. After airway stabilization if needed, the best treatment and optimal treatment time for BAO are not known but reperfusion approaches involving IV t-PA and/or endovascular therapy are appropriate within 4.5 hours. Data for endovascular treatment beyond 4.5 hours are based more on case series but could be considered on an individual basis, particularly in those patients with very severe deficits and imaging that shows mild or minimal ischemic changes. Randomized trials have been difficult because of relatively low incidence rates and lack of equipoise. Further research should focus on quicker diagnosis, appropriate imaging, and optimal treatment for this patient population.
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Advanced imaging with CTA or MRI may help with decision making where small core with high NIHSS score may suggest greater potential benefit.
9,8
Outcomes after IA thrombolysis vs IA thrombectomy are inconclusive, but IA thrombectomy devises have better outcomes in the anterior circulation 10,11
Anticoagulation as bridging therapy or definitive therapy Inconclusive and lacking data. Decisions to treat with heparin drip and/or anticoagulation should be made on a case-by-case basis Abbreviations: BAO, basilar artery occlusion; CTA, computed tomography angiography; IA, intra-arterial; MRI, magnetic resonance imaging; t-PA, tissue-type plasminogen activator; NIHSS, National Institutes of Health Stroke Scale.
